Privia Health Group (NASDAQ:PRVA) Price Target Raised to $23.00 at Barclays

Privia Health Group (NASDAQ:PRVA) had its price objective hoisted by Barclays from $22.00 to $23.00 in a report published on Monday morning,Benzinga reports. They currently have an equal weight rating on the stock.

Several other brokerages have also weighed in on PRVA. Stephens reaffirmed an “overweight” rating and issued a $32.00 target price on shares of Privia Health Group in a research report on Wednesday, September 24th. Evercore ISI increased their price objective on shares of Privia Health Group from $28.00 to $30.00 and gave the stock an “outperform” rating in a report on Friday. Truist Financial reissued a “buy” rating and set a $31.00 target price (up from $30.00) on shares of Privia Health Group in a research note on Monday. Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 19th. Finally, Citizens Jmp lifted their price target on Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a report on Friday. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.58.

Privia Health Group Stock Down 0.1%

PRVA opened at $23.41 on Monday. The company’s 50-day moving average price is $24.15 and its 200 day moving average price is $22.76. Privia Health Group has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The firm has a market cap of $2.87 billion, a price-to-earnings ratio of 180.09, a price-to-earnings-growth ratio of 3.32 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The company had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%. Research analysts anticipate that Privia Health Group will post 0.14 earnings per share for the current year.

Institutional Trading of Privia Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. CWM LLC boosted its holdings in shares of Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after acquiring an additional 604 shares in the last quarter. Russell Investments Group Ltd. lifted its position in Privia Health Group by 2,852.2% in the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after purchasing an additional 2,567 shares during the period. Caitong International Asset Management Co. Ltd lifted its position in Privia Health Group by 2,115.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock worth $75,000 after purchasing an additional 3,173 shares during the period. Vestcor Inc bought a new position in Privia Health Group during the 1st quarter valued at $76,000. Finally, Canada Pension Plan Investment Board increased its position in shares of Privia Health Group by 48.0% during the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after purchasing an additional 1,200 shares during the period. 94.48% of the stock is currently owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.